This site is intended for Healthcare Professionals only

MHRA

asthma-1280x720

First twice yearly biological medicine for asthma gets UK approval

The first twice-yearly biological medicine for use as an add-on treatment for asthma has been approved by the MHRA.

16 Dec 2025

hayfever-1280x720

Fluticasone 0.05pc nasal spray reclassified to be available for children aged 12 and over

MHRA reclassifies fluticasone nasal spray as a P medicine for those aged 12 years and over, available from February 2026.

16 Dec 2025

patient-info-leaflet-1280

Antidepressant patient leaflets should be clearer about suicide risk, concludes review

The MHRA said several “communication measures” were agreed, including a patient card which will be supplied by healthcare professionals.

05 Dec 2025

tuberculosis-summary

Limit TB drugs to one month’s supply, warns MHRA amid shortages

Prioritise active TB cases to conserve supplies, MHRA tells prescribers

31 Jul 2025

Recall 1280.jpg

Pharmacists urged to stop supplying batches of paracetamol amid contamination fears

The MHRA issued a “precautionary recall” of two batches of Chelonia Healthcare Limited’s Paracetamol 500mg Tablets after discoloured tablets were found in some packs.

10 Jun 2025

weight-loss-medication-new-1280

MHRA updates guidance on anti-obesity jabs amid safety concerns

The National Pharmacy Association said regulations and guidance must "keep pace” with the huge demand for weight loss medicines.

05 Jun 2025

crohns-1280x720

Guselkumab approved for treatment of Crohn’s and ulcerative colitis

Guselkumab already approved for plaque psoriasis and psoriatic arthritis, but studies show it is also effective in moderate to severe Crohn’s disease and UC.

20 May 2025

buy-now-summary

Illegal websites posing as regulated pharmacies, warns coroner after overdose death

Coroner reports on benzodiazepine death of vulnerable 45-year-old man in Wales

28 Apr 2025

eczema

Nemolizumab approved for prurigo nodularis and atopic dermatitis

Nemolizumab (Nemluvio, Galderma) has been approved by the MHRA for the treatment of two skins conditions.

18 Feb 2025

covid-research-2024-1280

MHRA approves adapted version of Comirnaty Covid vaccine

The MHRA approved two “presentations of the adapted vaccine” after they met its standards of safety, quality, and effectiveness.

11 Oct 2024

liver-1280x720

Elafibranor approved as first medicine to treat adults with a rare liver disease

Elafibranor (Iqirvo) has been approved by the MHRA to treat adult patients with a rare type of liver disease known as primary biliary cholangitis

08 Oct 2024

approved-1280

MHRA today approves new colorectal cancer medicine

Fruquintinib stops tumours making new blood vessels, which normally provide the tumour with nutrients and oxygen.

20 Sep 2024

approved-1280

First generic raltegravir medicines for HIV patients approved by MHRA

The MHRA has approved generic versions of raltegravir which reduce the amount of HIV in a patient’s blood when used with other medicines.

22 Jul 2024

topiramate-1280x720

New pregnancy prevention measures introduced for topiramate

Migraine and antiseizure medication topiramate (Topamax) must no longer be prescribed to women and girls unless they fulfil the requirements of a Pregnancy Prevention Programme

24 Jun 2024

Justice 1280.jpg

Two pharmacists sentenced for illegal supply of 55 million doses of controlled drugs

Mandip Sidhu, 47, of Littleover, Derby, and Nabeil Nasr, 42, of Cheadle, Greater Manchester, each received 24-month suspended sentences.

17 May 2024

pil-1280x720

Montelukast PIL updated to warn of neuropsychiatric reactions

MHRA says patients should be alert to behaviour and mood-related changes associated with the treatment, and seek urgent medical attention if neuropsychiatric reactions occur.

30 Apr 2024

Change privacy settings